Phillip G. Febbo
Chief Scientific & Med Officer · 5 filings · Latest: Sep 2, 2026
VERACYTE, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VCYT | Phillip G. Febbo | Chief Scientific & Med Officer | Sep 4, 2026 | Sale | $43.05 | 13,110 | $564.4K | 133,048 | |
VCYT | PHILLIP FEBBO | — | Sep 4, 2026 | Proposed Sale | $44.67 | 13,110 | $585.6K | — | |
VCYT | Phillip G. Febbo | Chief Scientific & Med Officer | Mar 2, 2026 | Sale | $36.16 | 13,425 | $485.4K | 117,346 | |
VCYT | PHILLIP FEBBO | — | Mar 2, 2026 | Proposed Sale | $36.59 | 13,425 | $491.2K | — | |
VCYT | PHILLIP FEBBO | — | Oct 6, 2025 | Proposed Sale | $36.00 | 8,349 | $300.6K | — | |
VCYT | PHILLIP FEBBO | — | Mar 4, 2025 | Proposed Sale | $33.56 | 8,037 | $269.7K | — | |
VCYT | PHILLIP G FEBBO | — | Dec 4, 2024 | Proposed Sale | $44.09 | 1,311 | $57.8K | — | |
VCYT | PHILLIP G FEBBO | — | Dec 4, 2024 | Proposed Sale | $43.66 | 2,623 | $114.5K | — |